{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.ai-analytics.org/drug-product/64980-220#drug","name":"Pyridostigmine Bromide","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"64980-220"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA205464"},{"@type":"PropertyValue","propertyID":"UNII","value":"KVI301NA53"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"f7a75639-a23a-4847-a962-c091c61947f0"}],"activeIngredient":"PYRIDOSTIGMINE BROMIDE","administrationRoute":["ORAL"],"dosageForm":"TABLET","manufacturer":{"@type":"Organization","name":"Rising Pharma Holdings, Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.ai-analytics.org/drug-approval/ANDA205464","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7a75639-a23a-4847-a962-c091c61947f0","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64980-220"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-09-27T05:55:33.965Z"}}